Medtronic (NYSE:MDT) today announced new real-world data from a post-approval study of its In.Pact AV drug-coated balloon (DCB). The IN.PACT AV Access post-approval study demonstrated strong safety and effectiveness for the DCB in the treatment of arteriovenous fistula (AVF) stenoses in patients with end-stage kidney disease on dialysis. The … [Read more...] about Medtronic has strong 1-year results for drug-coated balloon
Balloons
Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
Stryker (NYSE:SYK) announced today that it entered into a definitive agreement to acquire Amplitude Vascular Systems (AVS) for an undisclosed amount. Portage, Michigan-based Stryker’s latest strategic move marks its planned entry into the intravascular lithotripsy (IVL) space. IVL remains a hot space, with Johnson & Johnson’s Shockwave … [Read more...] about Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
MicroPort wins FDA breakthrough nod for drug-eluting stent
MicroPort announced that it received FDA breakthrough device designation for its Apollo Dream sirolimus target-eluting stent system. Apollo Dream, an investigational, balloon-expandable, rapid-exchange drug-eluting stent system, is designed to provide vascular scaffolding and restore. cerebral blood flow. It aims to treat intracranial … [Read more...] about MicroPort wins FDA breakthrough nod for drug-eluting stent
Airiver Medical wins FDA breakthrough nod for drug-coated balloon, treats first patient
Airiver Medical announced today that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB). Additionally, Airiver announced the first treated patients in a clinical trial for the DCB. The Brooklyn Park, Minnesota-based company designed its DCB to treat central airway stenosis. Central airway stenosis … [Read more...] about Airiver Medical wins FDA breakthrough nod for drug-coated balloon, treats first patient
Orchestra BioMed, Terumo terminate drug-eluting balloon distro deal in $30M agreement
Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with Terumo. The agreement relates to the New Hope, Pennsylvania–based company's Virtue Sirolimus AngioInfusion Balloon (SAB). It supersedes and terminates a prior distribution agreement between the companies and grants Terumo a … [Read more...] about Orchestra BioMed, Terumo terminate drug-eluting balloon distro deal in $30M agreement
Boston Scientific shares positive Agent drug-coated balloon findings
Boston Scientific (NYSE: BSX) today shared findings from new analyses of its Agent drug-coated balloon (DCB). Agent serves as an alternative to traditional therapies like balloon angioplasty, additional layers of stenting or radiation. The paclitaxel-coated balloon transfers a therapeutic dose of drug to the vessel wall, helping to prevent … [Read more...] about Boston Scientific shares positive Agent drug-coated balloon findings
Orchestra BioMed enrolls first patient in Sirolumus AngioInfusion balloon trial
Orchestra BioMed (Nasdaq:OBIO) today announced the first patient enrollments in a study of its Virtue Sirolimus AngioInfusion Balloon (SAB). The FDA investigational device exemption (IDE) trial compares the Virtue SAB to the Boston Scientific Agent paclitaxel-coated balloon. Agent is currently the only FDA-approved drug-coated balloon (DCB) for … [Read more...] about Orchestra BioMed enrolls first patient in Sirolumus AngioInfusion balloon trial
Multiple studies back Cordis Selution SLR drug-eluting balloon
Cordis today announced new findings from a duo of studies supporting the use of its Selution SLR drug-eluting balloon (DEB) system. Miami Lakes, Florida-based Cordis announced results from the SELUTION DeNovo and SELUTION 4ISR trials at the 2025 Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco. Both randomized clinical … [Read more...] about Multiple studies back Cordis Selution SLR drug-eluting balloon
Merit Medical to acquire cryoballoon tech from Pentax
Merit Medical Systems (Nasdaq:MMSI) announced an agreement to acquire the C2 CryoBalloon device from a Pentax Medical subsidiary. South Jordan, Utah-based Merit signed a definitive asset purchase agreement with Pentax of America over the C2 CryoBalloon and related technology. The companies expect the closing of the deal to occur during the fourth … [Read more...] about Merit Medical to acquire cryoballoon tech from Pentax
Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system
Medtronic today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device. The launch follows a limited market release and builds on Medtronic’s exclusive U.S. distribution agreement with the device’s developer Contego Medical. Neuroguard IEP combines a nitinol stent, dilation balloon and … [Read more...] about Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system
